Clive A. Meanwell
2016
In 2016, Clive A. Meanwell earned a total compensation of $6.7M as Chief Executive Officer at Medicines, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $853,418 |
|---|---|
| Option Awards | $3,450,640 |
| Salary | $896,447 |
| Stock Awards | $1,500,016 |
| Other | $2,935 |
| Total | $6,703,456 |
Meanwell received $3.5M in option awards, accounting for 51% of the total pay in 2016.
Meanwell also received $853.4K in non-equity incentive plan, $896.4K in salary, $1.5M in stock awards and $2.9K in other compensation.
Rankings
In 2016, Clive A. Meanwell's compensation ranked 1,003rd out of 14,075 executives tracked by ExecPay. In other words, Meanwell earned more than 92.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,003 out of 14,075 | 93rd |
Division Manufacturing | 334 out of 5,486 | 94th |
Major group Chemicals And Allied Products | 87 out of 1,900 | 95th |
Industry group Drugs | 58 out of 1,543 | 96th |
Industry Pharmaceutical Preparations | 49 out of 1,173 | 96th |
Source: SEC filing on April 26, 2017.
Meanwell's colleagues
We found four more compensation records of executives who worked with Clive A. Meanwell at Medicines in 2016.